A J Fisher1, S C Donnelly, G Pritchard, J H Dark, P A Corris. 1. Department of Cardiopulmonary Transplantation and Immunobiology and Transplantation Research Group, University of Newcastle upon Tyne, Freeman Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, UK.
Abstract
BACKGROUND: Donor organ shortage severely limits lung transplantation as a therapeutic option, yet many potential donor lungs are deemed unsuitable by clinical selection criteria. METHODS: Of 39 consecutive potential donor lungs, 14 were accepted and 25 excluded by clinical selection criteria. All were evaluated prospectively by clinical assessment, bronchoscopy, and bronchoalveolar lavage (BAL) to evaluate objectively the discrimination of pulmonary infection and injury. RESULTS: Accepted donors were significantly younger than those excluded (mean (SD) age 36.7 (15.3) years v 49.5 (13.2) years; p = 0.009, unpaired t test) and were more likely to have suffered traumatic brain death (50% v 20%; p = 0.07, Fisher's exact test). Oxygenation (PaO(2):FiO(2)) was higher in accepted donors than in excluded donors (median (range) 63.2 (48-82.5) kPa v 43.1 (7.7-71.7) kPa; p = 0.0001, Mann-Whitney test). Positive formal BAL culture was more frequent in accepted donors (75%) than in those excluded (43%; p = 0.1, Fisher's exact test). There was no significant difference in the percentage and concentration of neutrophils in BAL fluid between accepted and excluded donors (median (range) 37.9 (0-96.9)% and 44.6 (0-1190)x10(3)/ml v 36 (1-98.1)% and 46 (0.2-1457)x10(3)/ml), nor in the BAL fluid concentration of tumour necrosis factor-alpha (140 (0-340) pg/ml v 160 (0-760) pg/ml) or interleukin 8 (810 (33-17 600) pg/ml v 540 (0-15 110) pg/ml). CONCLUSION: Current selection criteria are poor discriminators of pulmonary injury and infection and lead to the exclusion of potentially usable donor lungs.
BACKGROUND:Donor organ shortage severely limits lung transplantation as a therapeutic option, yet many potential donor lungs are deemed unsuitable by clinical selection criteria. METHODS: Of 39 consecutive potential donor lungs, 14 were accepted and 25 excluded by clinical selection criteria. All were evaluated prospectively by clinical assessment, bronchoscopy, and bronchoalveolar lavage (BAL) to evaluate objectively the discrimination of pulmonary infection and injury. RESULTS: Accepted donors were significantly younger than those excluded (mean (SD) age 36.7 (15.3) years v 49.5 (13.2) years; p = 0.009, unpaired t test) and were more likely to have suffered traumatic brain death (50% v 20%; p = 0.07, Fisher's exact test). Oxygenation (PaO(2):FiO(2)) was higher in accepted donors than in excluded donors (median (range) 63.2 (48-82.5) kPa v 43.1 (7.7-71.7) kPa; p = 0.0001, Mann-Whitney test). Positive formal BAL culture was more frequent in accepted donors (75%) than in those excluded (43%; p = 0.1, Fisher's exact test). There was no significant difference in the percentage and concentration of neutrophils in BAL fluid between accepted and excluded donors (median (range) 37.9 (0-96.9)% and 44.6 (0-1190)x10(3)/ml v 36 (1-98.1)% and 46 (0.2-1457)x10(3)/ml), nor in the BAL fluid concentration of tumour necrosis factor-alpha (140 (0-340) pg/ml v 160 (0-760) pg/ml) or interleukin 8 (810 (33-17 600) pg/ml v 540 (0-15 110) pg/ml). CONCLUSION: Current selection criteria are poor discriminators of pulmonary injury and infection and lead to the exclusion of potentially usable donor lungs.
Authors: Andrew F Pierre; Yasuo Sekine; Michael A Hutcheon; Thomas K Waddell; Shaf H Keshavjee Journal: J Thorac Cardiovasc Surg Date: 2002-03 Impact factor: 5.209
Authors: Tarek M Aziz; Ahmed El-Gamel; Rasheed A G Saad; Marcello Migliore; Colin S Campbell; Nizar A Yonan Journal: Ann Thorac Surg Date: 2002-05 Impact factor: 4.330
Authors: V A Starnes; M S Woo; E F MacLaughlin; M V Horn; P C Wong; J M Rowland; C L Durst; W J Wells; M L Barr Journal: Ann Thorac Surg Date: 1999-12 Impact factor: 4.330
Authors: A J Fisher; S C Donnelly; N Hirani; C Haslett; R M Strieter; J H Dark; P A Corris Journal: Am J Respir Crit Care Med Date: 2001-01 Impact factor: 21.405
Authors: David Weill; Gerald C Dey; R Alan Hicks; K Randall Young; George L Zorn; James K Kirklin; Lesley Early; David C McGiffin Journal: J Heart Lung Transplant Date: 2002-05 Impact factor: 10.247
Authors: Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher Journal: J Heart Lung Transplant Date: 2017-05-12 Impact factor: 10.247
Authors: Anders S I Andreasson; Danai M Karamanou; Colin S Gillespie; Faruk Özalp; Tanveer Butt; Paul Hill; Kasim Jiwa; Hannah R Walden; Nicola J Green; Lee A Borthwick; Stephen C Clark; Henning Pauli; Kate F Gould; Paul A Corris; Simi Ali; John H Dark; Andrew J Fisher Journal: Eur J Cardiothorac Surg Date: 2017-03-01 Impact factor: 4.191
Authors: D F McAuley; G F Curley; U I Hamid; J G Laffey; J Abbott; D H McKenna; X Fang; M A Matthay; J W Lee Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-02-14 Impact factor: 5.464
Authors: John Robert Ferdinand; Morvern Isabel Morrison; Anders Andreasson; Catriona Charlton; Alisha Kaur Chhatwal; William Earl Scott; Lee Anthony Borthwick; Menna Ruth Clatworthy; Andrew J Fisher Journal: Clin Transplant Date: 2022-01-10 Impact factor: 3.456